Cargando…

Application of [18F]FLT-PET in pulmonary arterial hypertension: a clinical study in pulmonary arterial hypertension patients and unaffected bone morphogenetic protein receptor type 2 mutation carriers

Pulmonary arterial hypertension is a heterogeneous group of diseases characterized by vascular cell proliferation leading to pulmonary vascular remodelling and ultimately right heart failure. Previous data indicated that 3′-deoxy-3′-[18F]-fluorothymidine ((18)FLT) positron emission tomography (PET)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Botros, Liza, Jansen, Samara M.A., Ashek, Ali, Spruijt, Onno A., Tramper, Jelco, Noordegraaf, Anton V., Aman, Jurjan, Harms, Hans, de Man, Frances S., Huisman, Marc C., Zhao, Lan, Bogaard, Harm J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256252/ https://www.ncbi.nlm.nih.gov/pubmed/34276963 http://dx.doi.org/10.1177/20458940211028017

Ejemplares similares

Pulmonary hypertension with warm hands
por: Botros, Liza, et al.
Publicado: (2017)

Pulmonary arterial hypertension combined with a high cardiac output state: Three remarkable cases
por: Spruijt, Onno A., et al.
Publicado: (2013)

A systematic review with meta-analysis of biomarkers for detection of pulmonary arterial hypertension
por: Smits, A. Josien, et al.
Publicado: (2022)

Tyrosine Kinases and Endothelial Homeostasis in Pulmonary Arterial Hypertension: Too Hot to Handle?
por: Bogaard, Harm Jan, et al.
Publicado: (2022)

Neurohormonal modulation in pulmonary arterial hypertension
por: Peters, Eva L., et al.
Publicado: (2021)

Nutritional status in pulmonary arterial hypertension
por: Kwant, Chermaine T., et al.
Publicado: (2022)

Increased native T1-values at the interventricular insertion regions of precapillary pulmonary hypertension patients
por: Spruijt, Onno A, et al.
Publicado: (2015)

Treatment response in patients with idiopathic pulmonary arterial hypertension and a severely reduced diffusion capacity
por: van der Bruggen, Cathelijne E., et al.
Publicado: (2017)

Pulmonary arterial hypertension preceding idiopathic pulmonary fibrosis in a BMPR2 mutation positive patient
por: Raamsteeboers, Aniek J., et al.
Publicado: (2014)

Pulmonary hypertension
por: Vonk Noordegraaf, Anton, et al.
Publicado: (2016)

Predicting pulmonary hypertension with standard computed tomography pulmonary angiography
por: Spruijt, Onno A., et al.
Publicado: (2015)

Risk Factors for Hemoptysis in Idiopathic and Hereditary Pulmonary Arterial Hypertension
por: Tio, Darryl, et al.
Publicado: (2013)

Increased native T1-values at the interventricular insertion regions in precapillary pulmonary hypertension
por: Spruijt, Onno A., et al.
Publicado: (2015)

Cardiopulmonary exercise testing reveals onset of disease and response to treatment in a case of heritable pulmonary arterial hypertension
por: Trip, Pia, et al.
Publicado: (2012)

Vascular narrowing in pulmonary arterial hypertension is heterogeneous: rethinking resistance
por: Rol, Nina, et al.
Publicado: (2017)

Prognostic Relevance of Changes in Exercise Test Variables in Pulmonary Arterial Hypertension
por: Groepenhoff, Herman, et al.
Publicado: (2013)

Repurposing of medications for pulmonary arterial hypertension
por: Toshner, Mark, et al.
Publicado: (2020)

Blood Outgrowth and Proliferation of Endothelial Colony Forming Cells are Related to Markers of Disease Severity in Patients with Pulmonary Arterial Hypertension
por: Smits, Josien, et al.
Publicado: (2018)

Riociguat inhibits ultra‐large VWF string formation on pulmonary artery endothelial cells from chronic thromboembolic pulmonary hypertension patients
por: Jujo Sanada, Takayuki, et al.
Publicado: (2022)

Bisoprolol and/or hyperoxic breathing do not reduce hyperventilation in pulmonary arterial hypertension patients
por: Peters, Eva L., et al.
Publicado: (2021)

Recent advances in pulmonary arterial hypertension
por: Wilkins, Martin R., et al.
Publicado: (2018)

The UPHILL study: A nutrition and lifestyle intervention to improve quality of life for patients with pulmonary arterial hypertension
por: Kwant, Chermaine T., et al.
Publicado: (2023)

Pulmonary vascular remodeling and right heart failure in pulmonary hypertension: future role of positron emission tomography in decoding the enigma
por: Harms, Hendrik J, et al.
Publicado: (2013)

Right Ventricular Function During Exercise After Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension
por: Braams, Natalia J., et al.
Publicado: (2023)

Reply to “Bone morphogenetic protein's contribution to pulmonary artery hypertension”
por: King, Tyler, et al.
Publicado: (2016)

Genetic Evaluation in a Cohort of 126 Dutch Pulmonary Arterial Hypertension Patients
por: van den Heuvel, Lieke M., et al.
Publicado: (2020)

Sensitivity of a Simple Noninvasive Screening Algorithm for Chronic Thromboembolic Pulmonary Hypertension after Acute Pulmonary Embolism
por: Ende-Verhaar, Yvonne M., et al.
Publicado: (2018)

Cardiac magnetic resonance imaging in pulmonary arterial hypertension
por: Peacock, Andrew J., et al.
Publicado: (2013)

Epoprostenol and pulmonary arterial hypertension: 20 years of clinical experience
por: Sitbon, Olivier, et al.
Publicado: (2017)

The Value of Hemodynamic Measurements or Cardiac MRI in the Follow-up of Patients With Idiopathic Pulmonary Arterial Hypertension
por: van der Bruggen, Cathelijne Emma, et al.
Publicado: (2021)

Metabolic profile in endothelial cells of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension
por: Smolders, V. F. E. D., et al.
Publicado: (2022)

Pathways to experiencing mental problems and need for mental support in patients with pulmonary arterial hypertension
por: Muntingh, Anna D.T., et al.
Publicado: (2017)

Bisoprolol therapy does not reduce right ventricular sympathetic activity in pulmonary arterial hypertension patients
por: Rijnierse, Mischa T., et al.
Publicado: (2020)

Right Ventricular and Right Atrial Function Are Less Compromised in Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction: A Comparison With Pulmonary Arterial Hypertension With Similar Pressure Overload
por: van Wezenbeek, Jessie, et al.
Publicado: (2021)

Automated quantification of the pulmonary vasculature in pulmonary embolism and chronic thromboembolic pulmonary hypertension
por: Zhai, Zhiwei, et al.
Publicado: (2023)

Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Benza, Raymond L., et al.
Publicado: (2022)

Improvement in exercise capacity after a modified Potts shunt in an adult patient with pulmonary arterial hypertension
por: Symersky, Petr, et al.
Publicado: (2021)

Development of a 3-Dimensional Model to Study Right Heart Dysfunction in Pulmonary Arterial Hypertension: First Observations
por: Llucià-Valldeperas, Aida, et al.
Publicado: (2021)

Malnutrition in pulmonary arterial hypertension: a possible role for dietary intervention
por: Kwant, Chermaine T., et al.
Publicado: (2019)

The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient
por: Happé, Chris, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6agah1vabc5vptralij4jnricd